Drug details:
Molecular formula: C₁₈H₁₃N₃O₅

Standard name: 3-hydroxy-N-[(Z)-[5-(2-nitrophenyl)furan-2-yl]methylideneamino]benzamide

Curated SMILES: C1=CC=C(C(=C1)C2=CC=C(O2)/C=N\NC(=O)C3=CC(=CC=C3)O)[N+](=O)[O-]

Evidence for compound's anti-virulence activity:

Brucella
Related VF: VirB type IV secretion system
Target: VirB8
Drug effect: Inhibits T4SS by targeting an essential assembly protein VirB8.
Max phase: Preclinical (in vivo)
Publication:
Smith MA, et al., 2012. Identification of the binding site of Brucella VirB8 interaction inhibitors. Chem Biol 19(8):1041-8.